2026 Updates in Cancer Therapies (UCT): Moving Forward with a Review of the Latest Data is a comprehensive live CE event designed to deliver timely, practice-changing updates in oncology. This two-day in-person meeting held January 9–10, 2026, at the Hilton Aventura Miami Hotel in Aventura, Florida, will feature expert-led sessions, panel discussions, and interactive Q&A segments.

UCT 2026 brings together leading oncology experts to deliver the most critical updates from ASCO, ESMO, and other major meetings, translating the latest data into practical, patient-centered care strategies. The agenda spans advances across lung, breast, prostate, and colorectal cancers, other solid tumors, and hematologic malignancies such as chronic lymphocytic leukemia, B-cell and T-cell non-Hodgkin lymphomas, and multiple myeloma. Sessions will also highlight emerging technologies such as circulating tumor DNA (ctDNA) and its integration into modern oncology practice.

Developed by an expert educational committee with input from past participant evaluations, UCT 2026 aims to foster critical thinking, enhance clinical decision-making, and promote multidisciplinary and interprofessional approaches to patient-centered cancer care.

Register by

Saturday, January 10 @ 3:35pm

Viewing in Eastern Time